Characterization of circulating and endothelial progenitor cells in patients with extreme-duration type 1 diabetes

Diabetes Care

Volumn 37, Issue 8, 2014, Pages 2193-2201

  Hernandez, Sonia L ^a   Gong, Jennifer H ^a   Chen, Liming ^a,b   Wu, I Hsien ^a   Sun, Jennifer K ^a   Keenan, Hillary A ^a   King, George L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOPROSTANE DERIVATIVE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; BIOLOGICAL MARKER;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CELL COUNT; CELL LEVEL; CELL MIGRATION; CHOLESTEROL BLOOD LEVEL; CIRCULATING PROGENITOR CELL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ENDOTHELIAL PROGENITOR CELL; EXERCISE INTENSITY; FEMALE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROTEIN BLOOD LEVEL; STEM CELL; URINE LEVEL; BLOOD; CASE CONTROL STUDY; COMPLICATION; FLOW CYTOMETRY; METABOLISM; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; YOUNG ADULT;

ADULT; BIOMARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; ENDOTHELIAL PROGENITOR CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; YOUNG ADULT;

EID: 84905040914     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-2547     Document Type: Article

References (36)

1. Grant MB, May WS, Caballero S, et al Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 2002; 8: 607-612
2. Ingram DA, Lien IZ, Mead L.E., et al. In vitro hyperglycemia or a diabetic intrauterine environment reduces neonatal endothelial colonyforming cell numbers and function. Diabetes 2008; 57: 724-731
3. Lombardo MF, Iacopino P, Cuzzola M., et al. Type2 diabetesmellitus impairs the maturation of endothelial progenitor cells and increases the number of circulating endothelial cells in peripheral blood. Cytometry A 2012; 81: 856-864
4. Loomans CJ, de Koning EJ, Staal FJ, et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004; 53: 195-199
5. Werner N, Kosiol S, Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007
6. Moon JH, Chae MK, Kim K.J., et al. Decreased endothelial progenitor cells and increased serum glycated albumin are independently correlated with plaque-forming carotid artery atherosclerosis in type 2 diabetes patients without documented ischemic disease. Circ J 2012; 76: 2273-2279
7. Fadini GP, Miorin M, Facco M., et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005; 45: 1449-1457
8. van Ark J., Moser J, Lexis C.P., et al. Type 2 diabetes mellitus is associated with an imbalance in circulating endothelial and smooth muscle progenitor cell numbers. Diabetologia 2012; 55: 2501-2512
9. Tepper OM, Galiano RD, Capla J.M., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106: 2781-2786
10. Choi JH, Kim KL, Huh W, et al Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 2004; 24: 1246-1252
11. de Groot K., Bahlmann FH, Sowa J, et al Uremia causes endothelial progenitor cell deficiency. Kidney Int 2004; 66: 641-646
12. Herbrig K, Pistrosch F, Oelschlaegel U., et al. Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. Am J Kidney Dis 2004; 44: 840-849
13. Aicher A, Rentsch M, Sasaki K., et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res 2007; 100: 581-589
14. Asahara T, Masuda H, Takahashi T., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-228
15. Asahara T, Murohara T, Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967
16. Peichev M, Naiyer AJ, Pereira D, et al Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958
17. Sata M, Saiura A, Kunisato A., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8: 403-409
18. Hagensen MK, Shim J, Thim T., Falk E, Bentzon JF. Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis. Circulation 2010; 121: 898-905
19. Purhonen S, Palm J, Rossi D., et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci U S A 2008; 105: 6620-6625
20. Shintani S, Murohara T, Ikeda H., et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001; 103: 897-903
21. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004; 95: 343-353
22. Asahara T, Takahashi T, Masuda H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-3972
23. Ceradini DJ, Kulkarni AR, Callaghan M.J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004; 10: 858-864
24. Butler JM, Guthrie SM, Koc M, et al SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest 2005; 115: 86-93
25. Sayyed SG, Hägele H, Kulkarni O.P., et al. Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. Diabetologia 2009; 52: 2445-2454
26. Case J, Ingram DA, Haneline LS Oxidative stress impairs endothelial progenitor cell function. Antioxid Redox Signal 2008; 10: 1895-1907
27. Keenan HA, Costacou T, Sun J.K., et al. Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study. Diabetes Care 2007; 30: 1995-1997
28. Keenan HA, Sun JK, Levine J, et al Residual insulin production and pancreatic β-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 2010; 59: 2846-2853
29. Sun JK, Keenan HA, Cavallerano J.D., et al. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study. Diabetes Care 2011; 34: 968-974
30. Reinhard H, Jacobsen PK, Lajer M, et al Endothelial progenitor cells in long-standing asymptomatic type 1 diabetic patients with or without diabetic nephropathy. Nephron Clin Pract 2011; 118: c309-c314
31. Bassett DR, Vachon JA, Kirkland A.O., Howley ET, Duncan GE, Johnson KR. Energy cost of stair climbing and descending on the college alumnus questionnaire. Med Sci Sports Exerc 1997; 29: 1250-1254
32. Feldman EL, Stevens MJ, Thomas P.K., Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994; 17: 1281-1289
33. Levey AS, Stevens LA, Schmid C.H., et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
34. Ungvari Z, Kaley G, de Cabo R, Sonntag WE, Csiszar A. Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci 2010; 65: 1028-1041
35. Saxena A, Fish JE, White M.D., et al. Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation 2008; 117: 2224-2231
36. Li Q, Park K, Li C., et al. Induction of vascular insulin resistance and endothelin-1 expression and acceleration of atherosclerosis by the overexpression of protein kinase C-β isoform in the endothelium. Circ Res 2013; 113: 418-427